Pathological complete response in an advance stage IIIB non‐small cell lung cancer secondary to neoadjuvant osimertinib targeted therapy: A case report and review of literature

Neoadjuvant chemotherapy is a therapeutic option for potentially resectable non‐small cell lung cancer (NSCLC). The role of neoadjuvant targeted therapy (NTT) remains less explored. This case highlights the use of neoadjuvant osimertinib in a case of advanced NSCLC. A 67‐year‐old woman had a left lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Soo, Chun Ian, Ong, Diana Bee‐Lan, Chin, Ka Kiat, Sia, Leng Cheng, Munusamy, Vijayan, Ibrahim, Nur Husna, Loh, Thian Chee, Tan, Jiunn Liang, Poh, Mau Ern, Wong, Chee Kuan, Pang, Yong Kek, Liam, Chong Kin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282595/
https://www.ncbi.nlm.nih.gov/pubmed/37350988
http://dx.doi.org/10.1002/rcr2.1181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282595/
https://www.ncbi.nlm.nih.gov/pubmed/37350988
http://dx.doi.org/10.1002/rcr2.1181

Ejemplares similares